NAVANAPHAR Stock Overview
Engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 1/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Navana Pharmaceuticals PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳51.50 |
| 52 Week High | ৳118.90 |
| 52 Week Low | ৳36.20 |
| Beta | -0.065 |
| 11 Month Change | 14.19% |
| 3 Month Change | -23.13% |
| 1 Year Change | -35.63% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 95.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| NAVANAPHAR | BD Pharmaceuticals | BD Market | |
|---|---|---|---|
| 7D | 3.4% | -2.3% | -0.9% |
| 1Y | -35.6% | -25.3% | -20.0% |
Return vs Industry: NAVANAPHAR underperformed the BD Pharmaceuticals industry which returned -25.3% over the past year.
Return vs Market: NAVANAPHAR underperformed the BD Market which returned -20% over the past year.
Price Volatility
| NAVANAPHAR volatility | |
|---|---|
| NAVANAPHAR Average Weekly Movement | 9.0% |
| Pharmaceuticals Industry Average Movement | 8.3% |
| Market Average Movement | 7.0% |
| 10% most volatile stocks in BD Market | 9.3% |
| 10% least volatile stocks in BD Market | 3.9% |
Stable Share Price: NAVANAPHAR's share price has been volatile over the past 3 months compared to the BD market.
Volatility Over Time: NAVANAPHAR's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of BD stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 4,143 | Md. Shafiq | www.navanapharma.com |
Navana Pharmaceuticals PLC engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh. The company offers generic human health products in various forms, such as tablet, capsule, powder, cream, ointment, injection, eye and nasal drop, liquid, sachet, and oral solution. It also provides veterinary products, including vaccine, bolus, liquid, injection, water soluble powder, and premix.
Navana Pharmaceuticals PLC Fundamentals Summary
| NAVANAPHAR fundamental statistics | |
|---|---|
| Market cap | ৳5.53b |
| Earnings (TTM) | ৳404.63m |
| Revenue (TTM) | ৳6.90b |
13.7x
P/E Ratio0.8x
P/S RatioIs NAVANAPHAR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NAVANAPHAR income statement (TTM) | |
|---|---|
| Revenue | ৳6.90b |
| Cost of Revenue | ৳3.75b |
| Gross Profit | ৳3.14b |
| Other Expenses | ৳2.74b |
| Earnings | ৳404.63m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.77 |
| Gross Margin | 45.59% |
| Net Profit Margin | 5.87% |
| Debt/Equity Ratio | 115.5% |
How did NAVANAPHAR perform over the long term?
See historical performance and comparisonDividends
2.7%
Current Dividend Yield32%
Payout RatioDoes NAVANAPHAR pay a reliable dividends?
See NAVANAPHAR dividend history and benchmarks| Navana Pharmaceuticals dividend dates | |
|---|---|
| Ex Dividend Date | Nov 20 2024 |
| Dividend Pay Date | Jan 30 2025 |
| Days until Ex dividend | 2 days |
| Days until Dividend pay date | 69 days |
Does NAVANAPHAR pay a reliable dividends?
See NAVANAPHAR dividend history and benchmarks